Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Acelrx Pharmaceutica (NQ: ACRX )

1.370 USD UNCHANGED
Streaming Delayed Price Updated: 4:01 AM EDT, Apr 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Acelrx Pharmaceutica

< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers DiaMedica Therapeutics (NASDAQ:DMAC) shares increased by 6.17% to $9.98 during Thursday's after-market session. DiaMedica ... 
Tags AVIR Market News KMPH
From Benzinga
AcelRx To Test Dsuvia In Patients On Buprenorphine Requiring A Surgical Procedure
AcelRx Pharmaceuticals Inc(NASDAQ:ACRX) hasannounced an investigator-initiated studyto assess the ... 
Tags Market News Briefs FDA
From Benzinga
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Taking Buprenorphine Who Require a Surgical Procedure
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,... 
From PR Newswire
AcelRx Pharmaceuticals Announces Appointment of Marina Bozilenko to the Board of Directors
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today... 
From PR Newswire
ROCE Insights For AcelRx Pharmaceuticals
During Q4, AcelRx Pharmaceuticals's (NASDAQ:ACRX) reported sales totaled $738.00 thousand. Despite a 2.29% in earnings, the company ... 
Tags News ACRX BZI/ROCE
From Benzinga
Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference
Exciting and insightful biotech news was front and center at the Benzinga Biotech Small Cap Conference, a two-day event that kicked off ... 
Tags LTRN LEXX HOTH
From Benzinga
AcelRx Pharmaceuticals Announces Clinical Data Reporting High Ratings for Healthcare Professional and Patient Satisfaction Following Use of DSUVIA® for Acute Pain in Hospital Settings
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today... 
From PR Newswire
AcelRx Announces Presentation and Fireside Chat at the Benzinga Biotech Small Cap Conference
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,... 
From PR Newswire
First Week of May 21st Options Trading For AcelRx Pharmaceuticals (ACRX)
Investors in AcelRx Pharmaceuticals Inc (ACRX) saw new options begin trading this week, for the May 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ACRX... 
Tags Stocks
From Market News Video
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
66 Biggest Movers From Yesterday
Gainers SunLink Health Systems, Inc. (NYSE: SSY) shares climbed 151.3% to close at $4.85 on Tuesday as the company reported $2 ... 
Tags CLSK RFIL ENZ
From Benzinga
VTWG's Holdings Imply 10% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ACRX RMED INFI
From Benzinga
AcelRx Pharmaceuticals: Q4 Earnings Insights
Shares of AcelRx Pharmaceuticals (NASDAQ:ACRX) fellin after-market trading after the company reported Q4 results. Quarterly ... 
Tags Market News Benzinga Earnings
From Benzinga
AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results
Full year 2020 revenues of $5.4 million compared to $2.3 million in 2019 
From PR Newswire
Earnings Scheduled For March 15, 2021
Companies Reporting Before The Bell • Stratus Properties (NASDAQ:STRS) is projected to report earnings for its fourth ... 
Tags ACEL AMR BZI/UE
From Benzinga
Week Ahead In Biotech (March 14-20): Update On Fibrogen-AstraZeneca's Anemia Drug, Earnings and Presentations
Biotech stocks snapped back from their weekly losses and ended higher for the week ended March 12, with the broader market recovery ... 
Tags THMO RYTM LBPH
From Benzinga
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
Best Penny Stocks To Buy? Here’s What Analysts Think Of These 4
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
2 Penny Stocks That Could Make You Filthy Rich
AcelRx Pharmaceuticals and Sundial Growers could both be poised for a major growth spurt. 
Tags SNDL Market News ACRX
From Motley Fool
AcelRx to Host Fourth Quarter and Full Year 2020 Financial Results Call and Webcast on March 15, 2021
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release fourth quarter financial results after market close on Monday, March 15, 2021.... 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX)
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at... 
From PR Newswire
AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery Procedures
AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,... 
From PR Newswire
ROCE Insights For AcelRx Pharmaceuticals
During Q3, AcelRx Pharmaceuticals's (NASDAQ:ACRX) reported sales totaled $1.37 million. Despite a 32.24% in earnings, the company ... 
Tags Benzinga Earnings General
From Benzinga
68 Biggest Movers From Yesterday
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 414.3% to close at $8.28 on Wednesday after the company announced a ... 
Tags ANCN APM CLXT
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Obalon Therapeutics (NASDAQ:OBLN) shares rose 384.47% to $7.8 during Wednesday's regular session. The ... 
Tags CLXT Markets ACER
From Benzinga
45 Stocks Moving In Wednesday's Mid-Day Session
Gainers Obalon Therapeutics Inc (NASDAQ: OBLN) shares jumped 175% to $4.4250 after the company announced a merger agreement with ... 
Tags TLSA NFLX CLBS
From Benzinga
Why AcelRx Pharmaceuticals Stock Is Sinking Today
The company announced the pricing of a public stock offering. 
Tags Market News ACRX
From Motley Fool
AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock
AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX) (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions,... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback